Skip to content
★ Sign in to follow
CS

Clas Sonesson

IRLAB Therapeutics AB
Total declarations
5
Company
1
▲ Purchases (2 ops.)
€11k
▼ Sales (0 ops.)
—

Latest filing published 26 Feb 2020 for IRLAB Therapeutics AB, €13k.

Filing timeline

BuySale
Clas Sonesson

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Clas Sonesson: trading record in brief

This profile gathers the share dealings of Clas Sonesson in IRLAB Therapeutics AB. The record holds 5 filings, for trades running from 17 February 2017 to 25 February 2020.

On the market, this insider has only ever bought: 2 purchases, €11k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

The latest filing, published on 26 February 2020, reports a transaction of €13k in IRLAB Therapeutics AB. The last insider purchase was made public on 27 February 2017, 3,542 days ago. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for notifying a trade is three business days (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Clas Sonesson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ●
    CSOExecutivesIRLAB Therapeutics AB
    139,995 SEK0FI-SE
    5,185 shares@ SEK 27.00100.0% of flowBTA (betald tecknad aktie)ISIN SE0013748332FI:csv-e1b5518785703359e5cf
  • ●
    ForskningschefExecutivesIRLAB Therapeutics AB
    3M SEK0FI-SE
    31,299 shares@ SEK 92.18AktieISIN SE0012675379FI:csv-5e216c60c77f67fcb2fb
  • ▲
    ForskningschefExecutivesIRLAB Therapeutics AB
    49,980 SEK0FI-SE
    833 shares@ SEK 60.00ISIN SE0009242225FI:csv-5af34301ba21485e1ba7
    Canonical exit: 25 May 2017 (T+90)
  • ▲
    ForskningschefExecutivesIRLAB Therapeutics AB
    49,980 SEK0FI-SE
    833 shares@ SEK 60.00ISIN SE0009242225FI:csv-c2d644ef0259fc88a57d
    Canonical exit: 18 May 2017 (T+90)

4 of 4 declarations